COVID-19 vaccination programme for Spring 2025
The Government has announced the COVID-19 vaccination programme for Spring 2025.
Epilepsy medicine manufacturers fined for charging excessive prices
Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for “charging excessive prices” between 2012 and 2016.
Royal Pharmaceutical Society (RPS) report calls on the Government to create a national strategy to manage medication shortages
Epilepsy Society welcomes the report from RPS, Medicines Shortages: solutions for empty shelves which calls on the Government to create a national strategy to manage medication shortages.
Health minister responds to call for review of medicines supply chain
The Epilepsy Society was pleased to receive a reply from Health Minister, Karin Smyth in response to our letter calling for a top-to-toe review of the medicines supply chain.
It’s never right to use epilepsy to “go compare”
We are always quick to call out any publications or broadcasters who use epilepsy-related terms in an inappropriate and offensive manner, even when it is sloppy journalism and presenting and there is no deliberate intent to cause harm and upset.
One-stop clinic offers cardiology alongside neurology
A unique one-stop clinic for people with Dravet syndrome has been launched at the Epilepsy Society’s Chalfont Centre.